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Objectives: Owing to its structural and anatomic characteristics, imaging of the lymphatic system has been difficult. The
conventional diagnostic method of radionuclide-based imaging has the disadvantage of poor resolution. Recent work has
shown that magnetic resonance imaging (MRI) can depict lymphatic channels in patients with lymphedema. This study
evaluated the anatomic and functional images of contrast MR lymphangiography in the diagnosis of limb lymphatic
circulation disorders.
Methods: The study enrolled 27 patients with primary lymphedema. Four patients had bilateral disease, and 23 had
unilateral disease. Contrast-enhanced lymphangiography was performed with a 3.0-T MR unit after the intracutaneous
injection of gadobenate dimeglumine into the interdigital webs of the dorsal foot. The kinetics of enhanced lymph flow
within the lymphatic system were calculated using the formula [speed in cm  total length of visualized lymph vessel in
cm/inspection time in minutes] and by comparing dynamic nodal enhancement and time-signal intensity curves between
edematous and contralateral limbs. Morphologic abnormalities of the lymphatic system were also evaluated.
Results: Examination of the MRIs after injection of the contrast agent showed enhanced lymphatic channels consistently
visualized in all clinical lymphedematous limbs and in five contralateral limbs of unilateral lymphedema patients. The
speed of flow within the lymphatics of lymphedematous limbs was 0.3 to 1.48 cm/min. Contrast enhancement in
inguinal nodes of edematous limbs was significantly less than that of contralateral limbs (P< .01). Dynamic measurement
of contrast enhancement showed a remarkable lowering of peak time (P < .01) and peak enhancement (P < .01), and a
delay in outflow in inguinal nodes of affected limbs compared with that of control limbs. Postcontrast MRI also depicted
varied distribution patterns of lymphatics and abnormal lymph flow pathways within lymph nodes in the limbs with
lymphatic circulation disorders.
Conclusion: Contrast MR lymphangiography with gadobenate dimeglumine is capable of visualizing the precise anatomy
of lymphatic vessels and lymph nodes in lymphedematous limbs. It also provides information concerning the functional
status of lymph flow transport in the lymphatic vessels and lymph nodes of these limbs. (J Vasc Surg 2009;49:980-7.)The development of clinical lymphology was slow for
many years. This was largely due to the lack of optimal
diagnostic methods for assessing lymphatic diseases, in-
cluding lymphatic system imaging. Lymphoscintigraphy
using isotopic contrast agents does not have sufficient
resolution to accurately outline the internal anatomy of
lymph nodes and lymphatic vessels. The measurement of
tracer clearance from the injection point and accumulation
of tracer in the inguinal lymph node may be valuable in
functional analysis, but it has limited diagnostic accuracy.
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980In addition, direct lymphangiography using an iodine oil
agent that is capable of visualizing the lymphatics is no
longer routinely performed because it can lead to life-
threatening complications and is difficult to perform. Fur-
thermore, neither method can be used to make a dynamic
observation of the lymphatic system and lymph nodes. It is,
therefore, essential to find an imaging modality that in
addition to mapping the anatomic distribution of the af-
fected lymphatic system is also capable of defining its func-
tion.
Magnetic resonance imaging (MRI) has been used in our
clinic for diagnosis of lymphatic disorders1,2 since 1990.MRI
has a number of potential advantages compared with lym-
phoscintigraphy, including higher spatial resolution en-
abling depiction of lymphatic channels, higher temporal
resolution, production of three-dimensional (3D) images,
and the absence of exposure to ionizing radiation. In recent
years, a number of different contrast agents have also been
developed and tested in MR lymphangiography for imag-
ing of the lymphatic system.3-7 Most of these agents are
intravenously injected for the staging of malignant lymph
nodes or to show lymphatic drainage patterns.
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phy after the intracutaneous injection of gadobenate dime-
glumine in patients with benign lymphatic circulation dis-
orders of the extremities. To our knowledge, this is the first
report of the usefulness of dynamic MR lymphangiography
in the imaging of the lymphatic system in human limbs with
lymphatic circulation disorders.
METHODS
Patients. The present study included 27 patients (17
males, 10 females) with a mean age 28 of years (range, 8-75
years) and a mean duration of disease of 7.8 years (range, 4
months-28 years). Among them, four had stage I lymphed-
ema, which represents an early accumulation of fluid that
subsides with limb elevation, and the remainder had stage
II disease, which signifies tissue swelling that is rarely
reduced by limb elevation alone and some degree of tissue
fibrosis in the limb.
Contrast. The contrast agent used for MR lym-
phangiography in this study is the commercially available
and widely used paramagnetic contrast medium gado-
benate dimeglumine (Gd-BOPTA, MultiHance, Bracco,
Milan, Italy). Before injection, 1% lidocaine (1.5 mL) was
added to each bottle of gadobenate dimeglumine (15 mL),
and the mixed agent was injected intracutaneously into the
interdigital webs of the dorsal foot, with four injections in
each limb. The volume injected into each point was 0.7 to
0.8 mL.
Dynamic 3D-MR lymphangiography. All MR ex-
aminations were performed with a 3.0-T MR unit (Philips
Medical System, Best, The Netherlands) with a maximum
gradient strength of 80 mT/m and a slew rate of 200
mT/m/ms. Patients were supine. A six-element phased-
array sensitivity encoding cardiac reception coil was used.
The scanning was started from the patient’s foot and
moved towards the inguinal region in three or four separate
and successive inspections according to length of the body.
Before injection of the contrast agent, a 3D heavily
T2-weighted MRI was performed. The serial turbo se-
quences included fat saturation and half-scan acquisition,
single-shot fast spin-echo sequence. The repetition time
(TR) was 2820 milliseconds, the echo time (TE) was 740
milliseconds, field of view (FOV) was 360  285 mm,
matrix was 240  190, and slice thickness was 2 mm, with
55 to 85 slices produced. A series of maximum intensity
projection (MIP) images were reconstructed. For dynamic
MR lymphangiography, 3D fast spoiled gradient-recalled
echo T1-weighted images with a fat saturation technique
(T1 high-resolution isotropic volume excitation) were ac-
quired at 5, 10, 15, 20, 25, and 30 minutes after contrast
injection. The MR imaging parameters were TR/TE, 3.5/
1.7 milliseconds; flip angle, 25°; FOV, 360  320 mm;
matrix, 300 256; slices, 55 to 95; voxel size, 1.51.2
1.2 mm; signal average number, 2; and acquisition time, 0
min 40 seconds.
The 3D MRIs were then reconstructed from the post-
contrast coronal images at each time point using an MIP
technique. The examination time for one patient was ap-proximately 1.5 hours. No systemic or local complications
were observed during or after the examination.
Image interpretation and data analysis. The con-
trast enhancement of the lymph vessels and lymph nodes of
the lower extremities and inguinal region was qualitatively
and quantitatively evaluated independently by two observ-
ers. The appearance and distribution pattern of the lym-
phatic pathway in the diseased extremities and the morpho-
logic characteristics of the inguinal nodes on the MRIs
before and after contrast were analyzed. The existence and
location of edema in the affected limbs were evaluated. A
quantitative analysis was also performed, including:
1. Assessment of the time course of enhancement of lymph
flow in vessels directly draining from the injection sites.
After contrast injection, the measurement of contrast
movement in a contrast-enhanced lymphatic vessel was
assessed from the ankle region along its course towards
the proximal leg in a series of five to six successive images
along the enhanced lymph vessel with a clear outline.
The length of the enhanced vessel on the final image was
recorded and the speed of contrast movement was cal-
culated using the formula [speed in cm total length of
visualized lymph vessel in cm/ inspection time in min-
utes].
2. Assessment of enhancement of inguinal lymph nodes
directly draining from the injection sites. For evaluating
these results, the ratio of signal intensity (SI) of the
lymph node against the SI of adjacent muscle was esti-
mated. The operator-defined regions of interest (ROIs)
were drawn on the coronal postcontrast images. At least
of one pair of inguinal nodes wasmeasured. The ROI on
muscles was selected in the upper portion of the thigh
near the inguinal region with lymph nodes that were
approximately the same size. The ratio of node/muscle
SI was compared between lymphedematous and con-
tralateral limbs on postcontrast MRIs. For each patient,
the dynamic enhancement of contrast in the bilateral
nodes was estimated, the wash-in and wash-out curves
were derived from designated ROIs, and the peak en-
hancement time and lymph node/muscle SI ratio at
peak time were directly compared.
Statistical analysis. All results were expressed as
means with standard deviations. The paired t test was used
to compare the significance of the differences between
mean values. A value of P  .05 was taken to indicate a
significant difference.
RESULTS
Lymphatic system imaging
Lymphatic drainage patterns. Contrast enhance-
ment of the lymphatic system was seen soon after contrast
injection, and the contrast agent generated clear images of
the lymphatic vessels and lymph nodes with a low back-
ground. On the postcontrast MRIs, consistently enhanced
images of the lymphatic channel were visualized in all
lymphedematous limbs, although contrast-enhanced lym-
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healthy volunteers. However, contrast-enhanced lymphatic
vessels could be seen in five contralateral nonedematous
limbs of the 23 patients with unilateral primary lymphed-
ema. The contrast enhancement of these lymphatic path-
ways persisted for about 40 minutes during the examina-
tion. The initial images the enhancement of lymphatic
channels was light and discontinuous in some cases; how-
ever, the SI increased and the channels gradually become
totally opacified with time. No leakage of contrast from the
lymphatic vessels was seen, but dermal backflow was ob-
served the distal part of the leg and foot in three patients.
The number of contrast-enhanced lymphatic vessels in
the primary lymphedematous limbs varied from a single
vessel to numerous vessels, and lymphatic vessels that could
be visualized had diameters of 1.2 to 8 mm. Lymphatic
vessels in edematous limbs were also irregularly shaped, had
an uneven diameter or were twisted, and could be easily
distinguished from venous vessels. Patterns seen in the
lymphatic pathways of patients with primary lymphedema
included:
● numerous tiny skin lymphatic vessels and dermal back-
flow in the lower part of the leg, plus one or two dilated
lymphatic collectors in the upper part of the leg (Fig 1,a);
● radiating, enhanced vessels in lower leg that assembled
at the medial portion of the knee and went up to the
thigh (Fig 1, b);
● discontinuous and lightly enhanced but dilated vessels
in the medial portion of the lower limb (Fig 1, c);
● bunches of extremely dilated and significantly en-
hanced lymphatic vessels located mainly in the medial
and, to a lesser extent, the lateral portion of the thigh
(Fig 1, d); and
● remarkably dilated and opacified lymphatic vessels that
went from the lower leg directly to the inguinal node
with few branches (Fig 1, e and f).
Fine afferent and efferent lymph vessels between the super-
ficial and deep groups of inguinal nodes were also clearly
visualized in some limbs.
TheMRIs also provided information on extralymphatic
changes by showing the location and extent of edema fluid.
Indeed, accumulation of edema fluid in subcutaneous tis-
sue and contrast-enhanced lymphatic vessels could be visu-
alized in all 27 patients with primary lymphedema.
Contrast transportation in lymphatic channels.
Contrast-enhanced lymph flow speed was measured in 25
patients; among them, 23 limbs in 20 patients were avail-
able for dynamic observation of the contrast-enhanced flow
at a series of time points. The speed of the enhanced lymph
flow was 0.3 to 1.48 cm/min (Fig 2, b), and the mean flow
speed of the lymph vessels at each time point in the 23 limbs
is shown in Fig 2, c.
Possible correlations between the transporting capabil-
ities of these vessels and their diameter, the number of
lymphatic vessels in each affected limb, and disease duration
were compared. The speed of enhanced lymph flow was
compared between subgroups of vessel diameters (10 at2mm, 16 at 2 to 5 mm, and 6 at 5 to 8 mm), numbers of
visualized lymphatic vessels (10 with 1 to 2; 9 with 3 to 20;
and 6 with20), and lymphedema duration (6 at1 year;
11 at 2 to 5 years; and 10 at 5 years). No significant
differences were found in enhanced flow speed between the
vessels with different diameters or between subgroups with
different disease duration.
Furthermore, the observed kinetic result of lymph flow
in an individual vessel did not appear related to the numbers
of lymphatic vessels in the affected limbs (Fig 2, d). How-
ever, we noted that the speed of lymph transport might
depend on the individual patient; for example, in one
patient with primary lymphedema in the left lower extrem-
Fig 1. A 3-dimensional contrast magnetic resonance lym-
phangiography displayed various lymphatic drainage pathways.
a, Increased skin lymphatic and dermal back-flow in the media and
lateral region of lower leg (arrow) and dilated collectors in the
upper part of leg (arrowhead). b, Radiating arranged dilated
vessels in the lower leg of primary lymphedema cases. c, Enhanced
lymphatic vessels (arrowheads) distributed as a slender network
over the lower extremity. d, Bunches of extremely dilated and
significantly highlighted lymphatic vessels (arrowheads) located in
the medial and lateral portion of the thigh. e, Single enhanced and
dilated lymphatic (arrowheads) with irregular outline in the leg of
primary lymphedema. f, An intensely enhanced dilated lymph
vessel (arrowheads) with clear outline in the thigh.ity of20 years, the tested speed of flowwas 1.25 cm/min,
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study. The diameter of the imaged vessels in the patient was
6.1 mm, which was also within the highest range in the
study (Fig 1, f).
Lymph node imaging
Morphologic characteristics of the inguinal lymph
nodes. The morphologic changes, including nodal size,
internal lymph node architecture, and lymph node borders,
were also evaluated. The shape of the inguinal lymph node
on the contralateral side in patients with lymphedema and
in healthy volunteers was spherical or oval, and inguinal
nodes in these patients numbered from 2 or 3 to 7 or 8,
with a diameter of approximately 1.0 cm. In contrast, large
variation was noted in the outline, number, and volume of
inguinal nodes in primary lymphedematous extremities.
Compared with contralateral limbs, the abnormalities of
Fig 2. Dynamic images of enhanced lymph flow. a,
lymphedematous limb. b, Enhanced flow speed (cm/m
of lymphedematous limbs. c, Mean flow speed is chart
line in the middle of each box indicates the median; the
percentiles, respectively. The whiskers mark the 90th a
groups with various vascular diameters, vascular num
standard deviation.inguinal nodes in lymphedematous limbs included no visu-alized nodes; a single, large node about 5 cm long; round,
fibrotic nodes with homogeneous higher density; multiple
small nodules of about 0.5 cm; nodes with an irregular
border and homogeneous architecture; irregular nodal out-
line with homogeneous architecture; and enlarged nodes
about 5 to 6 cm with an increased number. Enhanced
popliteal nodes were also visualized in two women with
primary stage I lymphedema.
Transportation of contrast in lymph nodes. En-
hancement of contrast in the inguinal nodes started 30 to
40 minutes after the intracutaneous contrast agent injec-
tion. At this time, the inguinal nodes of two healthy volun-
teers and the limbs without clinical edema were markedly
enhanced. A comparison was made of the lymph node/
muscle SI ratio between nodes of edematous limbs and con-
tralateral nodes in the normally appearing limbs in 19 patients.
rvation of movement of contrast-enhanced flow in a
t a series time points is shown for of 23 lymph vessels
each time point of 23 tested vessels.* The horizontal
nd bottom borders of the box mark the 75th and 25th
th percentiles. d, Comparison of lymph speed in three
and disease durations. Data are presented with theObse
in) a
ed at
top a
nd 10
bersThe postcontrast MRIs of 34 pairs of nodes showed remark-
entra
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the nodes of edematous limbs and contralateral limbs in
patients with unilateral lymphedema (Fig 3, a) as well as in
the two patients with bilateral lymphedema in whom
edema was serious in one limb and mild in the other. The
Fig 3. Contrast magnetic resonance lymphangiographi
lation of contrast between the nodes with heterogeneou
(arrow) and contralateral nodes that were evenly enhan
afferent collectors (arrowheads) of a limb with lymphan
arrow) in contrast to highlighted nodes (arrow) in a lim
(arrow) that are irregularly shaped are compared with
d,Central region of the enhanced node with a regular out
of contrast in the marginal region of the nodes and left cnode/muscle SI ratio in lymphedematous limbs after con-trast enhancement was also significantly lower than in con-
tralateral limbs (P  .01). The exception was one patient
with Klippel-Trenaunay syndrome, in whom an increased
number of enlarged inguinal nodes (about 5 cm in length)
and increased contrast enhancement in these large nodes
ging of inguinal lymph nodes. a, asymmetrical accumu-
earance and poor enhancement in the edematous limb
(arrowhead). b, Contrast-enhanced flow is detained in
asia without enhancement in the drainage nodes (short
hout edema. c, Contrast-enhanced central part of nodes
ly enhanced contralateral healthy nodes (arrowhead).
the edematous limb is shown. e,Contrast enhancement
l region unenhanced.c ima
s app
ced
giect
b wit
even
line incompared with contralateral nodes was seen.
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varied patterns of contrast material passing through and
accumulating within inguinal nodes of 19 patients with
lymphedema limbs. A constant homogeneous signal loss in
the inguinal node was found in four patients (4/19); in
three patients, this was due to total fibrosis of the nodes;
and in one patient, it was caused by the contrast material
stagnating in the extremely dilated prenodal lymphatic
collectors and not reaching the nodes during the test (Fig
3, b). In two patients, contrast enhancement appeared
mainly in the central zone of the nodes, giving a heteroge-
neous appearance (Fig 3, c and d). In nine patients, contrast
enhancement was mainly in the marginal region of the nodes
while the central region of the nodes remained unenhanced
(Fig 3, e).
Dynamic contrast-enhanced MRIs of inguinal lymph
nodes were also available in nine patients. Wash-in and
wash-out curves derived from designated ROIs in 14 pairs
of nodes displayed a decreased slope and slower wash-out
(Fig 4, a), remarkable reduced peak enhancement (P .01,
Fig 4, b), and a significantly longer time to peak enhance-
ment (P  .01, Fig 4, c) in the edematous limbs.
DISCUSSION
In this study, we present for the first time an analysis of
contrast MR lymphangiography with gadobenate dimeglu-
mine in the diagnosis of lymphatic circulation disorders.
This test provided a quick and accurate method of visual-
izing the lymphatic pathway and lymph nodes in lymphed-
ematous limbs. Lymphatic vessels in a limb with lymph flow
disturbances were visualized, but the lymphatic vessels in a
healthy limb were not. This might be due to the faster flow
speed of lymph in the healthy limb. Thus, lymph circulation
disorders should be suspected when contrast-enhanced
lymphatics are visualized with this test.
Transportation of the contrast agent by the draining
lymphatic system and regional lymph nodes also allowed a
consecutive and real-time inspection of the transport func-
tion of the lymphatic system and the lymph nodes within a
reasonable length of time. Furthermore, the specificity of
absorption and transportation of the contrast agent by the
lymphatic system allowed visualization of detailed morpho-
logic changes of lymphatic vessels and regional lymph
nodes by using high-resolution MRIs. Finally, quantitative
assessment of abnormal lymph flow kinetics was achieved
by tracing the flow within the lymphatic vessels and com-
paring dynamic nodal enhancement and time-signal inten-
sity curves between edematous and contralateral limbs.
This combination of the lymphatic and lymph node
images may outline the integral picture of the affected
lymphatic system. Because of its advantages compared with
the conventional diagnostic method for lymphedema of
lymphoscintigraphy and noncontrast MRI, contrast MR
lymphangiography is now the routine diagnostic tool for
lymphedema in our clinic. The comprehensive information
provided by contrast MR lymphangiography not only helps
in the differential diagnosis of lymphedema from othertypes of peripheral edema but also enhances our under-
standing of the pathophysiology of lymphostatic diseases.
Shortly after injection, contrast material was absorbed
by lymphocytes, and the lymphatic system was visualized in
all lymphedematous limbs regardless of disease duration or
lymphatic vessel distribution. Thus, there was no failure of
contrast agent absorption and transportation in the injec-
tion site, indicating no dysfunction at the primary lym-
phatic level and also demonstrating spontaneous contrac-
tion and transportation capability of lymphatic vessels.
Lymph flow in lymphatic channels may be influenced by
multiple factors, and the ways pathologic abnormalities influ-
ence lymph flow kinetics remain largely unknown. Indeed,
MR contrast lymphangiography demonstrated a variety of
lymphatic distribution patterns, diameters, and numbers of
vessels and nodes in primary lymphedema, which may repre-
sent different mechanisms of pathogenesis. Regardless, the
causal relationship between lymph flowkinetics and lymphatic
system pathologies needs to be determined to allow more
direct and effective treatment of lymphedema.
In the lymph node, lymphatic fluid drains from the
afferent lymphatic vessels into the marginal sinus, circulates
through a complex cortical and medullar sinus network,
and exits through the efferent vessel into the blood circu-
lation. Flow resistance is 100 times greater in the lymph
nodes than in the lymph collectors.8 Lymphatic circulation
disorders may be caused solely by lymph node abnormali-
ties, by a lymphatic vessel problem, or a combination of
lymphatic and lymph node abnormalities.9,10However, the
influence of nodal factors on peripheral lymph flow failure
remains unclear. Nodal imaging in nonmalignant lympho-
static diseases has been described in a few reports, and
enhanced MR lymphangiography has proved useful for the
diagnosing and staging of malignant lymph nodes.5-8,11
The present study shows the usefulness of contrast MR
lymphangiography in detecting morphologic and functional
abnormalities of draining lymph nodes in benign lymphatic
disorders. This included highlighting of the medullar region
first, which is the opposite of normal intranodal lymph flow,
and enhancement of marginal sinuses regions with central
fillingdefects. In addition, delayednodal enhancement onwas
found in 18 of 19 tested cases. The dysfunction of prenodal
lymphatic collector transportationmay thus play an important
role in reduced nodal lymph flow input.However, the decline
of nodal enhancement over time, partial nodal enhancement,
and changed nodal filling patterns suggest the existence of
intranodal pathology. Real-time monitoring of nodal trans-
porting functions showed a significantly longer peak enhance-
ment time, reduced peak enhancement, decreased curve
slope, and slower wash-out, which may be direct evidence of
nodal involvement in lymphatic circulation failure.
Themolecular size of the contrast agent may have impor-
tant effect in lymphatic imaging.12 The optimum size that
preferentially drains through the lymphatic system remains
unclear. The ideal contrast agent for identifying lymphatic
pathways and regional lymph nodes would be specially ab-
sorbed by the initial lymphatic system, delivered in a high
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ground concentration in the surrounding healthy tissue.
Commonly used radionuclides in the lymphoscintigra-
Fig 4. Coronal images of dynamic enhancement of lymph node
enhancement in edematous (arrow) and nonedematous (arrowhe
the affected limb in contrast with a quick wash-in and wash-out cu
intensity ratios (n  14) in affected limbs were significantly lower
significantly longer time to peak enhancement (n  14). Data a
statistical significance.phy are macromolecules such as isotope-labeled albumin(about 60 kDa) and dextran (70 to 80 kDa). These mac-
romolecular contrast agents are passively absorbed by the
terminal lymphatic system through the open conjunctions
r contrast injection. a, Real-time record of comparison of nodal
mbs in a series images. The wash-in curve was prolonged in (left)
n (right) the unaffected limb. b, Peak time node vs muscle signal
that of unaffected limbs. c, Nodes of edematous limbs displayed
sented as mean with the standard deviation. P  0.01 indicatess afte
ad) li
rve i
than
re preof endothelial cells.13 However, sometimes superficial lym-
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visualized by lymphoscintigraphic imaging when these
agents are used.13,14 This may be due to stasis of the
isotopic contrast in the injection site or dysfunction at the
initial lymphatic level.
The paramagnetic contrast agent we used in this study to
visualize the anatomy and physiology of superficial extremity
lymphatic vessels and draining lymph nodes was gadobenate
dimeglumine, a micromolecular weight (about 1 kDa) con-
trast agent. It has special properties that may allow differential
targeting of lymphatic vessels and uptake by lymph nodes.15
Good uptake was demonstrated in both draining lymphatic
and regional nodes after intracutaneous injection. This agent
also provided good visualization of lymphatic vessels and
lymph nodes and an excellent, specific, signal-to background
ratio.
The precise mechanism of uptake of gadobenate dime-
glumine by lymphatic vessels and lymph nodes is not un-
derstood. The agent probably drains from the dermal to
lymphatic pathway through thin-walled lymphatic vessels
and gaps between endothelial cells. This depends on a
combination effect of hydrostatic pressure, osmosis, and
volumes, similar to other extracellular, water-soluble, low-
molecular solutes.16,17 The visualization of individual
nodes may be related to slow transit and sequestration of
the contrast material in each node.13 It is currently un-
known whether use of a micromolecular or a macromolec-
ular contrast agent produces different imaging results.
Because this is a preliminary study, there are many areas
for future research. It would be useful to determine the
pathogenesis of each functional lymphatic system abnor-
mality detected by MR lymphangiography, particularly for
abnormalities associated with regional lymph nodes. It
would also be useful to compare the effects of using a micro-
molecular contrast agent with a macromolecular agent inMR
lymphangiography. Finally, it would be interesting to study
whether initial absorption and transportation of macromole-
cules by lymphatic vessels can be accurately tested by using
micromolecular contrast MR imaging.
CONCLUSIONS
We present a useful modality for imaging the extremity
lymphatic system in patients with lymphedema. Contrast MR
lymphangiographywith gadobenate dimegluminewas able to
visualize the precise anatomy of lymphatic vessels and lymph
nodes in lymphedematous limbs. This method is minimally
invasive, is easy and safe to use, and combines morphologic
and functional examinations in a single process. The compre-
hensive information provided by contrast MR lymphangiog-
raphy can be used to characterize the lymphatic system in a
limb with lymph circulation disorders and may be useful in
staging and classification of primary lymphostatic diseases and
assessment of the response to treatment.
We extend our thanks to Bin-Shun Wang, director of
the Department of Statistics, Shanghai Jiao Tong Univer-
sity School of Medicine, for statistical analysis.AUTHOR CONRTIBUTIONS
Conception and design: NL
Analysis and interpretation: NL, QL, CW
Data collection: NL, Ql, ZJ, JZ
Writing the article: NL, QL
Critical revision of the article: NL
Final approval of the article: NL
Statistical analysis: NL
Obtained funding: NL
Overall responsibility: NL
REFERENCES
1. LiuNF,WangCG. The role ofmagnetic resonance imaging in diagnosis
of peripheral lymphatic disorders. Lymphology 1998;31:119-27.
2. Liu NF, Wang CG, Sun MH. Non-contrast three–dimensional magnetic
resonance imaging vs lymphoscintigraphy in the evaluation of lymph cir-
culation disorders: a comparative study. J Vasc Surg 2005;41:69-75.
3. Barrett T, Choyke PL, Kobayashi H. Imaging of the lymphatic system:
new horizons. Contrast Med Mol Imaging 2006;1:230-45.
4. Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic
lymph node metastases with MRI and MR lymphangiography. Abdom
Imaging 2003;28:155-63.
5. Al-Nahhas A, Win Z, Al-Sayed Y, Khan S, Sinch A, Rubello D, et al.
Anatomic and functional imaging in the management of lymphoma.
Q J Med Mol Imaging 2007;51:251-9.
6. Kobayashi H, Kawamoto S, Brechbiel MW, Bernardo M, Sato N, Wald-
mann TA, et al. Detection of lymph node involvement in hematologic
malignancies using micromagnetic resonance lymphangiography with a
gadolinium-labeled dendrimer nanoparticle. Neoplasia 2005;7:984-91.
7. Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV,
Choyke PL. Delivery of gadolinium-labeled nanoparticles to the senti-
nel lymph node: comparison of the sentinel node visualization and
estimations of intra-nodal gadolinium concentration by the magnetic
resonance imaging. J Control Release 2006;111:343-51.
8. Kubik S. Anatomy of the lymphatic system. In: Foldi M, Foldi E, Kubik
S. Textbook of lymphology. München: Elsevier GmbH; 2003. p. 34-5.
9. Kinmonth JB, Eustace PW. Lymph nodes and vessels in primary lym-
phoedema. Ann R Coll Surg Engl 1976;58:278-84.
10. Kinmonth JB, Wolfe JH. Fibrosis in the lymph nodes in primary
lymphoedema, histological and clinical studies in 74 patients with
lower-limb oedema. Ann R Coll Surg Engl 1980;62:344-54.
11. Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi M, et
al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-
enhanced imaging alone suffice for accurate lymph node characteriza-
tion? AJR Am J Roentgenol 2006;186:144-8.
12. Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Wald-
mann TA, et al. Comparison of dendrimer-based macromolecular con-
trast agents for dynamic micro-magnetic resonance lymphangiography.
Magn Reson Med 2003;50:758-66.
13. Pecking AP, Alberini JL, Wartski M, Edeline V, Cluzan RV. Relationship
between lymphoscintigraphy and clinica findings in lower limb lymphed-
ema (LO): toward a comprehensive staging. Lymphology 2008;41:1-10.
14. Brice G, Mansour S, Bell R, Collin JRO, Child AH, Brady AF, et al.
Analysis of the phenotypic abnormalities in lymphedema-distichiasis
syndrome in 74 patients with FOXC2 mutations or linkage to 16q64.
J Med Genet 2002;39:478-83.
15. Suga K, Yuan Y, Ogasawara N, Okada M, Matsunaga N. Visualization
of normal and interrupted lymphatic drainage in dog legs with intersti-
tial MR lymphography using an extracellular MR contrast agent, gado-
pentetate dimeglumine. Invest Radiol 2003;38:349-5.
16. Ruehm SG, Corot C, Debatin JF. Interstitial MR lymphography with a
conventional extracellular gadolinium-based agent: assessment in rab-
bits. Radiology 2001;218:664-9.
17. Ruehm SG, Schroeder T, Debatin JF. Interstitial MR lymphangiogra-
phy with gadoterate meglumine: initial experience in humans. Radiol-
ogy 2001;220:816-21.Submitted Jun 26, 2008; accepted Nov 7, 2008.
